These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 9786477)
41. Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial. Schuetz P; Christ-Crain M; Wolbers M; Schild U; Thomann R; Falconnier C; Widmer I; Neidert S; Blum CA; Schönenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Müller B; BMC Health Serv Res; 2007 Jul; 7():102. PubMed ID: 17615073 [TBL] [Abstract][Full Text] [Related]
42. Importance of nondrug costs of intravenous antibiotic therapy. van Zanten AR; Engelfriet PM; van Dillen K; van Veen M; Nuijten MJ; Polderman KH Crit Care; 2003 Dec; 7(6):R184-90. PubMed ID: 14624694 [TBL] [Abstract][Full Text] [Related]
43. Experiences at a large teaching hospital with levofloxacin for the treatment of community-acquired pneumonia. Clark LC; Davis CW Am J Health Syst Pharm; 2000 Nov; 57 Suppl 3():S10-3. PubMed ID: 11098314 [TBL] [Abstract][Full Text] [Related]
44. Medicare coverage of outpatient ambulatory intravenous antibiotic therapy: a program that pays for itself. Tice AD; Poretz D; Cook F; Zinner D; Strauss MJ Clin Infect Dis; 1998 Dec; 27(6):1415-21. PubMed ID: 9868653 [TBL] [Abstract][Full Text] [Related]
45. [Evaluation of the effectiveness, safety and costs of outpatient intravenous antimicrobial treatment (OPAT) vs hospitalized in urinary infection in pediatrics]. Peña A; Zambrano A; Alvarado M; Cerda J; Vergara R Rev Chilena Infectol; 2013 Aug; 30(4):426-34. PubMed ID: 24248113 [TBL] [Abstract][Full Text] [Related]
48. A new approach to treatment of resistant gram-positive infections: potential impact of targeted IV to oral switch on length of stay. Desai M; Franklin BD; Holmes AH; Trust S; Richards M; Jacklin A; Bamford KB BMC Infect Dis; 2006 Jun; 6():94. PubMed ID: 16762061 [TBL] [Abstract][Full Text] [Related]
49. Home intravenous antimicrobial therapy provided by a community hospital and a university hospital. Smego RA; Gainer RB Am J Hosp Pharm; 1985 Oct; 42(10):2185-9. PubMed ID: 4061460 [TBL] [Abstract][Full Text] [Related]
50. Modeling economic implications of alternative treatment strategies for acute bacterial skin and skin structure infections. Revankar N; Ward AJ; Pelligra CG; Kongnakorn T; Fan W; LaPensee KT J Med Econ; 2014 Oct; 17(10):730-40. PubMed ID: 25019580 [TBL] [Abstract][Full Text] [Related]
51. Home intravenous antibiotics for cystic fibrosis. Balaguer A; González de Dios J Cochrane Database Syst Rev; 2008 Jul; (3):CD001917. PubMed ID: 18646082 [TBL] [Abstract][Full Text] [Related]
52. Cellulitis: Home Or Inpatient in Children from the Emergency Department (CHOICE): protocol for a randomised controlled trial. Ibrahim LF; Babl FE; Orsini F; Hopper SM; Bryant PA BMJ Open; 2016 Jan; 6(1):e009606. PubMed ID: 26754176 [TBL] [Abstract][Full Text] [Related]
53. Cost of Gram-negative resistance. Evans HL; Lefrak SN; Lyman J; Smith RL; Chong TW; McElearney ST; Schulman AR; Hughes MG; Raymond DP; Pruett TL; Sawyer RG Crit Care Med; 2007 Jan; 35(1):89-95. PubMed ID: 17110877 [TBL] [Abstract][Full Text] [Related]
54. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia. Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135 [TBL] [Abstract][Full Text] [Related]
55. [Cost comparison of hospital and ambulatory i.v. therapy in adult cystic fibrosis patients. Results of a controlled prospective study]. Krauth C; Busse R; Smaczny C; Ullrich G; Wagner TO; Weber J; Welte T Med Klin (Munich); 1999 Oct; 94(10):541-8. PubMed ID: 10554512 [TBL] [Abstract][Full Text] [Related]
56. A cost analysis of Outpatient Parenteral Antibiotic Therapy (OPAT): an Asian perspective. Yong C; Fisher DA; Sklar GE; Li SC Int J Antimicrob Agents; 2009 Jan; 33(1):46-51. PubMed ID: 18823759 [TBL] [Abstract][Full Text] [Related]
57. Resource use and cost of care for patients hospitalised with community acquired pneumonia: impact of adherence to infectious diseases society of america guidelines. Orrick JJ; Segal R; Johns TE; Russell W; Wang F; Yin DD Pharmacoeconomics; 2004; 22(11):751-7. PubMed ID: 15250752 [TBL] [Abstract][Full Text] [Related]
58. Adherence to guideline-based antibiotic treatment for acute exacerbations of chronic obstructive pulmonary disease in an Australian tertiary hospital. Fanning M; McKean M; Seymour K; Pillans P; Scott I Intern Med J; 2014 Sep; 44(9):903-10. PubMed ID: 24963727 [TBL] [Abstract][Full Text] [Related]
59. A cost consequences analysis of local corticosteroid injection and physiotherapy for the treatment of new episodes of unilateral shoulder pain in primary care. James M; Stokes EA; Thomas E; Dziedzic K; Hay EM Rheumatology (Oxford); 2005 Nov; 44(11):1447-51. PubMed ID: 16091398 [TBL] [Abstract][Full Text] [Related]
60. Use and cost of hospital and community service provision for children with HIV infection at an English HIV referral centre. Beck EJ; Mandalia S; Griffith R; Beecham J; Walters MD; Boulton M; Miller DL Pharmacoeconomics; 2000 Jan; 17(1):53-69. PubMed ID: 10747765 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]